Maria Ignez Braghiroli

Maria Ignez Braghiroli


Physician graduated from the Federal University of Bahia, clinical oncologist graduated from the University of São Paulo and specialized in gastrointestinal tract tumors at Memorial Sloan Kettering. Dedicated to comprehensive patient care in conjunction with a multidisciplinary team. Special interest in clinical research and advances in cancer therapy. 

Keywords: Gastrointestinal cancer; clinical research; colorectal cancer 


Physician at the São Paulo State Cancer Institute

Physician Rede D'Or

Coordinator of the Oncology Residency at Rede D'Or in São Paulo





1st place in the "Doctorate pre-qualification" category of the Oncology Conference - FMUSP 2022

Selected Publications

Braghiroli MI, Sabbaga J, Hoff PM. Bevacizumab: overview of the literature. Expert Rev Anticancer Ther. 2012 May;12(5):567-80. PMID: 22594892.
doi: 10.1586/era.12.13 

Doki, Y., Ajani, J. A., Kato, K., Xu, J., Wyrwicz, L., Motoyama, S., Ogata, T., Kawakami, H., Hsu, C.-H., Adenis, A., El Hajbi, F., Di Bartolomeo, M., Braghiroli, M. I., et al. Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma. New England Journal of Medicine, 2022, 386(5), 449–462.
doi: 10.1056/NEJMoa2111380 

Tabernero J, Van Cutsem E, Bang Y-J, Fuchs CS, Wyrwicz L, Lee KW, Kubada I, Garrido M, Chung HC, Salguero HRC, Mansoor W, Braghiroli MIFM, et al. Pembrolizumab with or without chemotherapy versus chemotherapy for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The phase III KEYNOTE-062 study. Journal of Clinical Oncology. 2019 Jun 20;37(18_suppl):LBA4007–7.
doi: 10.1200/JCO.2019.37.18_suppl.LBA4007 

Connell LC, Mota JM, Braghiroli MI, Hoff PM. The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment. Curr Treat Options Oncol. 2017 Apr;18(4):23. PMID: 28391421.
doi: 10.1007/s11864-017-0463-3 

Shitara K, Van Cutsem E, Bang YJ, Fuchs C, Wyrwicz L, Lee KW, Kudaba I, Garrido M, Chung HC, Lee J, Castro HR, Mansoor W, Braghiroli MI, et al. Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial. JAMA Oncol. 2020 Oct 1;6(10):1571-1580. PMID: 32880601; PMCID: PMC7489405.
doi: 10.1001/jamaoncol.2020.3370 

More Content